MyFinsight
Home
Blog
About
US
$100,900K
(-49.09%↓ Y/Y)
Non Us
$13,200K
(-11.41%↓ Y/Y)
Revenue From Contract
With Customer...
$39,800K
Revenue From Contract
With Customer...
$36,800K
Net loss
-$43,200K
(86.93%↑ Y/Y)
Cancer Care Continuum
$114,100K
Prenatal Health
$39,800K
Mental Health
$36,800K
Loss before income
tax
-$42,600K
(87.11%↑ Y/Y)
Income tax expense
(benefit)
$600K
(700.00%↑ Y/Y)
Revenue
$190,700K
(-10.51%↓ Y/Y)
Operating loss
-$38,900K
(88.18%↑ Y/Y)
Total other expense,
net
-$3,700K
(-164.29%↓ Y/Y)
Gross profit
$127,000K
(-16.34%↓ Y/Y)
Interest income
$400K
(100.00%↑ Y/Y)
Cost of revenue
$63,700K
(3.92%↑ Y/Y)
Total operating
expenses
$165,900K
(-65.51%↓ Y/Y)
Interest expense
$4,100K
(173.33%↑ Y/Y)
Sales and marketing
expense
$83,100K
(15.58%↑ Y/Y)
General and
administrative expense
$57,800K
(-13.47%↓ Y/Y)
Research and development
expense
$25,000K
(-2.34%↓ Y/Y)
Back
Back
Income Statement
MYRIAD GENETICS INC (MYGN)
MYRIAD GENETICS INC (MYGN)
source: myfinsight.com